A phase II study of gemcitabine in combination with oxaliplatin as first-line chemotherapy in patients with inoperable biliary tract cancer

Cancer Chemotherapy and Pharmacology

Volumn 64, Issue 2, 2009, Pages 371-377

  Kim, Hyun Jung ^a   Lee, Nam Su ^a   Lee, Sang Cheol ^a   Bae, Sang Byung ^a   Kim, Chan Kyu ^a   Cheon, Young Gook ^a   Kim, Young Seok ^a   Moon, Jong Ho ^a   Cho, Young Deok ^a   Park, Sang Heum ^a   Lee, Kyu Taek ^a   Park, Sung Kyu ^a   Won, Jong Ho ^a   Park, Hee Sook ^a   Hong, Dae Sik ^a  

^a Soonchunhyang University   (South Korea)

Author keywords

Biliary tract cancer; Chemotherapy; Gemcitabine; Oxaliplatin

Indexed keywords

GEMCITABINE; OXALIPLATIN;

ADULT; AGED; ARTICLE; BILIARY TRACT CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG SENSITIVITY; FATIGUE; FEMALE; HUMAN; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUTROPENIA; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA; THROMBOSIS; TREATMENT OUTCOME; TREATMENT REFUSAL; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BILIARY TRACT NEOPLASMS; BONE NEOPLASMS; DEOXYCYTIDINE; FEMALE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; PERITONEAL NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 67349115384     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-008-0883-7     Document Type: Article

References (34)

1. HR Shin KW Jung YJ Won JG Park 2004 2002 annual report of the Korea central cancer registry: based on registered data from 139 hospitals Cancer Res Treat 36 103 114
2. Bartlett DL, Ramanathan RK, Deutsch M (2005) Cancer of the biliary tree. In: DeVita VT, Hellman S, Rosenberg SA (eds) CANCER principle and practice of oncology, 7th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1009-1035
3. B Glimelius K Hoffman PO Sjödén 1996 Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer Ann Oncol 7 593 600 (Pubitemid 26285639)
4. YZ Patt DV Jones Jr A Hoque 1996 Phase II trail of intravenous fluorouracil and subcutaneous interferon alfa-2b for biliary tract cancer J Clin Oncol 14 2311 2315 (Pubitemid 26264882)
5. CW Choi IK Choi JH Seo 2000 Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas Am J Clin Oncol 23 425 428 (Pubitemid 32429160)
6. M Ducreux E Van Cutsem JL Van Laethem 2005 A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial Eur J Cancer 41 398 403 (Pubitemid 40187211)
7. M Ducreux P Rougier A Fandi 1998 Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin Ann Oncol 9 653 656 (Pubitemid 28318199)
8. M Penz GV Kornek MU Raderer 2001 Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer Ann Oncol 12 183 186 (Pubitemid 32223865)
9. JO Gallardo B Rubio M Fodor 2001 A phase II study of gemcitabine in gallbladder carcinoma Ann Oncol 12 1403 1406 (Pubitemid 33100245)
10. J Harder B Riecken O Kummer 2006 Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer Br J Cancer 95 848 852 (Pubitemid 44498100)
11. ST Kim JO Park J Lee 2006 A phase II study of gemcitabine and cisplatin in advanced biliary tract cancer Cancer 106 1339 1346 (Pubitemid 43363912)
12. BK Park YJ Kim JY Park 2006 Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer J Gastroenterol Hepatol 21 999 1003 (Pubitemid 43823285)
13. AM Murad RC Guimaraes BC Aragao 2003 Phase II trial of the use of gemcitabine and 5-fluorouracil in the treatment of advanced pancreatic and biliary tract cancer Am J Clin Oncol 26 151 154 (Pubitemid 36443557)
14. J Lee TY Kim MA Lee 2008 Phase II trial of gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas Cancer Chemother Pharmacol 61 47 52 (Pubitemid 47512625)
15. S Faivre E Raymond JM Woynarowski E Cvitkovic 1999 Suppraadditive effect of 2?, 2?- difluorodeoxycytidine (gemcitabine) in combination with oxaliplatin in human cancer cell lines Cancer Chemother Pharmacol 44 117 123 (Pubitemid 29297057)
16. T André C Tournigand O Rosmorduc 2004 Gemcitabine and combined with oxliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study Ann Oncol 15 1339 1343 (Pubitemid 39295020)
17. C Louvet T André G Lledo 2002 Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study J Clin Oncol 20 1512 1518 (Pubitemid 34260530)
18. M Airoldi L Cattel R Passera F Pedani P Milla C Zanon 2006 Gemcitabine and oxaliplatin in patients with pancreatic adenocarcinoma: clinical and pharmacokinetic data Pancreas 32 44 50 (Pubitemid 41803646)
19. C Louvet R Labianca P Hammel 2005 Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial J Clin Oncol 23 3509 3516 (Pubitemid 46243495)
20. JW Eklund S Trifilio MF Mulcahy 2005 Chemotherapy dosing in the setting of liver dysfunction Oncology (Williston Park) 19 1057 1063 (Pubitemid 41725374)
21. M Tempero W Plunkett V Ruiz Van Haperen 2003 Randomized phase II comparison of dose-intense gemcitabine: Thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma J Clin Oncol 21 3402 3408 (Pubitemid 46594072)
22. JL Abbruzzese R Grunewald EA Weeks 1991 A phase I clinical, plasma, and cellular pharmacology study of gemcitabine J Clin Oncol 9 491 498
23. Z Guan Y Wang S Maoleekoonpairoj 2003 Prospective randomised phase II study of gemcitabine at standard or fixed dose rate schedule in unresectable hepatocellular carcinoma Br J Cancer 89 1865 1869 (Pubitemid 37533261)
24. C Gridelli C Gallo A Ceribelli 2007 Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC(GECO) study Lancet Oncol 8 500 512 (Pubitemid 46805905)
25. J Taïeb L Bonyhay L Golli 2003 Gemcitabine plus oxaliplatin for patients with advanced hepatocellular carcinoma using two different schedules Cancer 98 2664 2670 (Pubitemid 37509531)
26. F Eckel RM Schmid 2007 Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials Br J Cancer 96 896 902 (Pubitemid 46452283)
27. N Yonemoto J Furuse T Okusaka 2007 A multi-center retrospective analysis of survival benefits of chemotherapy for unresectable biliary tract cancer Jpn J Clin Oncol 37 843 851 (Pubitemid 350259003)
28. DC Doval JS Sekhon SK Gupta 2004 A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer Br J Cancer 90 1516 1520 (Pubitemid 38648231)
29. JJ Knox D Hedley A Oza 2005 Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial J Clin Oncol 23 2332 2338 (Pubitemid 46218726)
30. T André JM Reyes-Vidal L Fartoux 2008 Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study Br J Cancer 99 862 867
31. D Fink S Aebi SB Howell 1998 The role of DNA mismatch repair in drug resistance Clin Cancer Res 4 1 6 (Pubitemid 28062870)
32. N Kohya Y Kitajima K Kitahara K Miyazaki 2003 Mutation analysis of K-ras and beta-catenin genes related to O6-methylguanin-DNA methyltransferase and mismatch repair protein status in human gallbladder carcinoma Int J Mol Med 11 65 69
33. JW Adlard SD Richman MT Seymour P Quirke 2002 Prediction of the response of colorectal cancer to systemic therapy Lancet Oncol 3 75 82 (Pubitemid 34162977)
34. VW van Ruiz Haperen G Veerman S Eriksson 1994 Development and molecular characterization of a 2?, 2?-difluorodeoxycytidine-resistant variant of the human ovarian carcinoma cell line A2780 Cancer Res 54 4138 4143